BioPorto, The NGAL Test: Implementation into routine diagnostics, when?
Below are a couple of videos which hopefully may initiate a lengthy discussion about the value of novel biomarkers to diagnose acute kidney injury and if/when we might see these implemented into routine diagnostics.
“Biomarkers For Early Risk Assessment Of Acute Kidney Injury” :
“Novel Biomarkers for Acute Kidney Injury” :
“2012 ESICM Symposium – New AKI Biomarkers – Panel Discussion 1” :
There are quite a few youtube videos to be found relating to AKI and biomarkers, several, like the last one posted above, from ESICM (European Society of Intensive Care Medicine) 2012 – please do have a look and return here to discuss!
ISICEM (International Symposium on Intensive Care and Emergency Medicine) 2013 is held from today to March 22nd in Brussels.
2 Responses to BioPorto, The NGAL Test: Implementation into routine diagnostics, when?
Leave a Reply Cancel reply
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard


thanks SA – we'll add this article to our library…
More on NGAL – "The strength of NGAL in prediction of AKI" :
http://www.academypublish.org/paper/the-strength-…